Have a look at a recent success story of how Asphalion achieved Marketing authorization for a biosimilar medicine for a company located in East Asia that wanted to access the EU market.
Thanks to our extensive track record of over 20 year at Asphalion we can assist you with your all CMC activities, non-CMC specific ones and with all other kind of projects.
CLICK HERE TO SEE THE CASE STUDY IN DETAIL
For further information you can contact us at: [email protected]
Search News & Events
Share
We’re thrilled to announce that the web-based variations eAF is now ready for non-CAPs products across National Procedures (NP), Mutual Recognition Procedures (MRP), and Decentralized
Two years into the NABIHEAL project, Asphalion experts Marta Rayo Lunar and Sergio Veiga attended the consortium meeting in Zagreb, hosted by IMI, to review
Corneal blindness affects over 11.7 million people worldwide, yet only 1 in 70 patients receive a corneal transplant due to a severe donor shortage. The KeratOPrinter project aims to address this gap by developing a groundbreaking 4D bioprinting suite capable of producing fully functional, biocompatible human corneas. Combining expertise from world-class partners, the project focuses on scalable cell sources, advanced bioinks, high-precision bioprinting, clinical handling solutions, regulatory compliance, and a strong collaborative network. By 2035, KeratOPrinter seeks to revolutionize corneal transplantation and restore vision for millions.
Services
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
Memberships & PartnershipS
Quality Management System
Innovative SME
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
